J.H. Whitney Equity Partners V Sells 5,580 Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the firm’s stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $5.63, for a total value of $31,415.40. Following the sale, the insider now directly owns 1,451,598 shares in the company, valued at approximately $8,172,496.74. The trade was a 0.38 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Monday, March 24th, J.H. Whitney Equity Partners V sold 268 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.63, for a total transaction of $1,508.84.
• On Tuesday, March 18th, J.H. Whitney Equity Partners V sold 61,564 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.51, for a total transaction of $339,217.64.

Aveanna Healthcare Trading Down 5.3 %

Shares of NASDAQ AVAH traded down $0.30 during midday trading on Thursday, reaching $5.32. The company had a trading volume of 366,272 shares, compared to its average volume of 246,560. Aveanna Healthcare Holdings Inc. has a 1 year low of $2.11 and a 1 year high of $6.19. The business’s 50-day simple moving average is $4.77 and its 200 day simple moving average is $4.96. The stock has a market cap of $1.04 billion, a P/E ratio of -15.65 and a beta of 2.25.

Hedge Funds Weigh In On Aveanna Healthcare

Several hedge funds have recently made changes to their positions in the company. KLP Kapitalforvaltning AS purchased a new stake in Aveanna Healthcare during the 4th quarter valued at about $35,000. BNP Paribas Financial Markets purchased a new position in shares of Aveanna Healthcare in the fourth quarter worth about $35,000. Tower Research Capital LLC TRC boosted its position in Aveanna Healthcare by 662.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company’s stock valued at $36,000 after buying an additional 6,854 shares during the last quarter. Catalyst Funds Management Pty Ltd increased its holdings in Aveanna Healthcare by 321.4% in the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company’s stock worth $54,000 after buying an additional 9,000 shares during the period. Finally, Sagespring Wealth Partners LLC purchased a new position in Aveanna Healthcare during the 4th quarter worth approximately $57,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Truist Financial decreased their target price on shares of Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating for the company in a research report on Monday, January 6th. UBS Group upped their target price on Aveanna Healthcare from $3.20 to $4.50 and gave the company a “sell” rating in a research report on Friday, March 14th.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.